Literature DB >> 29093767

Corrigendum to "Metformin Decreases Reactive Oxygen Species, Enhances Osteogenic Properties of Adipose-Derived Multipotent Mesenchymal Stem Cells In Vitro, and Increases Bone Density In Vivo".

Krzysztof Marycz1,2, Krzysztof A Tomaszewski3, Katarzyna Kornicka1, Brandon Michael Henry3, Sebastian Wroński4, Jacek Tarasiuk4, Monika Maredziak2,5.   

Abstract

[This corrects the article DOI: 10.1155/2016/9785890.].

Entities:  

Year:  2017        PMID： 29093767      PMCID： PMC5594258          DOI： 10.1155/2017/5923818

Source DB:  PubMed          Journal:  Oxid Med Cell Longev        ISSN： 1942-0994            Impact factor:   6.543


In the article titled “Metformin Decreases Reactive Oxygen Species, Enhances Osteogenic Properties of Adipose-Derived Multipotent Mesenchymal Stem Cells In Vitro, and Increases Bone Density In Vivo” [1], an acknowledgment should be added as follows:
  1 in total

1.  Metformin Decreases Reactive Oxygen Species, Enhances Osteogenic Properties of Adipose-Derived Multipotent Mesenchymal Stem Cells In Vitro, and Increases Bone Density In Vivo.

Authors:  Krzysztof Marycz; Krzysztof A Tomaszewski; Katarzyna Kornicka; Brandon Michael Henry; Sebastian Wroński; Jacek Tarasiuk; Monika Maredziak
Journal:  Oxid Med Cell Longev       Date:  2016-04-18       Impact factor: 6.543
  1 in total
  3 in total

Review 1.  Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass.

Authors:  Mark F McCarty; Lidianys Lewis Lujan; Simon Iloki Assanga
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

2.  Linagliptin in Combination With Metformin Ameliorates Diabetic Osteoporosis Through Modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL/6 Mice.

Authors:  Nikita Nirwan; Divya Vohora
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

Review 3.  Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes.

Authors:  Lin Jiating; Ji Buyun; Zhang Yinchang
Journal:  Biomed Res Int       Date:  2019-11-26       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.